CN111388760A - Small blood vessel stent with nano fibers oriented along circumferential direction and preparation method - Google Patents
Small blood vessel stent with nano fibers oriented along circumferential direction and preparation method Download PDFInfo
- Publication number
- CN111388760A CN111388760A CN202010220104.9A CN202010220104A CN111388760A CN 111388760 A CN111388760 A CN 111388760A CN 202010220104 A CN202010220104 A CN 202010220104A CN 111388760 A CN111388760 A CN 111388760A
- Authority
- CN
- China
- Prior art keywords
- bacterial cellulose
- section
- vessel stent
- blood vessel
- circumferential direction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004204 blood vessel Anatomy 0.000 title claims abstract description 49
- 239000002121 nanofiber Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 229920002749 Bacterial cellulose Polymers 0.000 claims abstract description 81
- 239000005016 bacterial cellulose Substances 0.000 claims abstract description 81
- 239000000017 hydrogel Substances 0.000 claims abstract description 42
- 238000011065 in-situ storage Methods 0.000 claims abstract description 10
- 238000010438 heat treatment Methods 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 238000005516 engineering process Methods 0.000 claims abstract description 5
- 238000007493 shaping process Methods 0.000 claims abstract description 4
- 239000012528 membrane Substances 0.000 claims description 23
- 239000011521 glass Substances 0.000 claims description 20
- 239000001963 growth medium Substances 0.000 claims description 19
- 238000009835 boiling Methods 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 13
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000005507 spraying Methods 0.000 claims description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 244000235858 Acetobacter xylinum Species 0.000 claims description 4
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 4
- 241000589220 Acetobacter Species 0.000 claims description 3
- 244000283763 Acetobacter aceti Species 0.000 claims description 3
- 235000007847 Acetobacter aceti Nutrition 0.000 claims description 3
- 241000589212 Acetobacter pasteurianus Species 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 238000011549 displacement method Methods 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000002861 polymer material Substances 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 2
- 238000005070 sampling Methods 0.000 claims description 2
- 241000186339 Thermoanaerobacter Species 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000835 fiber Substances 0.000 abstract description 11
- 230000021164 cell adhesion Effects 0.000 abstract description 3
- 230000004663 cell proliferation Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 description 18
- 238000011161 development Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000589232 Gluconobacter oxydans Species 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 239000002473 artificial blood Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000000860 Compassion Fatigue Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Abstract
The invention discloses a small blood vessel stent with nanofibers oriented along the circumferential direction, which is composed of circumferentially arranged bacterial cellulose nanofibers, wherein the diameters of the nanofibers are smaller than 100 nanometers, the diameter of the small blood vessel stent is 2-6 millimeters, the thickness of a tube wall is controllable, and the minimum thickness can be as small as 10 micrometers. The preparation process comprises the following steps: preparing a bacterial cellulose hydrogel film with the length of 10-30 mm, the film thickness of 0.01-1 mm and the inner diameter of 2-6 mm on the outer rotary surface of a round rod with the diameter changing by adopting a film liquid interface culture technology, then moving the hydrogel film from the thin section end to the thick section end of the round rod to gradually increase the pipe diameter of the tubular bacterial cellulose hydrogel, forcing the bacterial cellulose fibers to be oriented in situ along the circumferential direction, and finally, taking out the round rod after heating, drying and shaping to obtain the bacterial cellulose hydrogel. The structure of the small blood vessel stent has similarity with the fiber arrangement structure of natural blood vessels, the performance of the small blood vessel stent is favorable for cell adhesion, proliferation and final endothelialization, and a better treatment effect is expected to be obtained.
Description
Technical Field
The invention relates to a biomedical engineering product, in particular to a small blood vessel stent.
Background
Cardiovascular disease is the leading enemy of human health today, with about 1/3 total deaths worldwide, and is growing rapidly. Vascular surgery is performed and replacement of diseased blood vessels is a recognized and effective clinical treatment. Autologous blood vessel transplantation is the clinical first choice, but the source is limited, and secondary trauma can be caused; the allogeneic blood vessels easily cause rejection reaction, blood coagulation and other defects; it is widely believed that the artificial blood vessel (stent) constructed by the tissue engineering method has the most development prospect. Since the first completion of artificial vascular artery transplantation surgery in 1952, human beings have made great progress and succeeded in large-caliber blood vessel transplantation. However, small-bore (less than 6mm) artificial blood vessels (hereinafter simply referred to as "small blood vessels") are a worldwide problem that has not been overcome so far because thrombi are very easy to form (rapid endothelialization is not easy). Therefore, the development of high-performance small vessel stents is a common pursuit goal of domestic and foreign scientists.
In vivo blood vessels are composed of circumferentially arranged fibers, and it is particularly important that the size of the fibers is in the range of nanometer (1-100 nm) to submicron (100-1000 nm), and that such nanostructures are likely to have a direct relationship with their antithrombotic formation. It follows that from a biomimetic perspective, the fibers of the small vessel scaffold should be composed of circumferentially arranged nanofibers. However, current techniques do not allow for small vessel stents with nanofibers oriented in the circumferential direction.
Disclosure of Invention
In view of the above problems, the present invention is directed to provide a small vessel stent with nanofibers oriented in the circumferential direction, which has a structure similar to the fiber arrangement structure of natural vessels, facilitates cell adhesion, proliferation and final endothelialization, and is expected to achieve a better therapeutic effect.
In order to solve the technical problems, the invention provides a small blood vessel stent with nanofibers oriented along the circumferential direction, which is formed by uniformly surrounding bacterial cellulose nanofibers into a circular tube shape, wherein the bacterial cellulose nanofibers are arranged along the circumferential direction, and the small blood vessel stent has an inner diameter of 2-6 mm, a wall thickness of 0.01-1 mm and a length of 10-30 mm. The preparation method mainly comprises the following steps: firstly, forming bacterial cellulose hydrogel on the rotary surface of a round bar in situ, gradually increasing the inner diameter of the tubular bacterial cellulose hydrogel by a displacement method to achieve the in-situ circumferential orientation of the nano fibers, heating, drying and shaping, and then removing the round bar to obtain the small vessel stent with the bacterial cellulose nano fibers oriented along the circumferential direction and the controllable tube wall thickness. The method comprises the following specific steps:
step one, preparing a culture medium by adopting a conventional method, and placing the culture medium in a sterilization pot for high-temperature and high-pressure sterilization for 30-60 minutes;
step two, preparing a bacterial cellulose base membrane: inoculating the strain into a culture medium in an aseptic environment; statically culturing the inoculated culture medium at 30 ℃ for 3 days to obtain a bacterial cellulose base membrane;
taking a round bar, wherein the round bar comprises an A section, a middle section and a B section which are coaxially connected in sequence; the diameter of the section A is Da, the Da is 1.5-4.5 mm, and the length of the section A is 10-30 mm; the diameter of the section B is Db, Db is 2-6 mm, Db is 1.3-1.4 Da, and the length of the section B is 10-30 mm; the diameter of the connecting end of the middle section and the section A is Da, the diameter of the connecting end of the middle section and the section B is Db, the length of the middle section is 100-200 mm, the middle section is a diameter gradually-changing section, and the diameter gradually changes from Da to Db along the length of the middle section; after ultraviolet sterilization, the round rod is fixed in an oxygen-permeable silica gel tube with a sampling hole at the upper end downwards according to the section A, and is vertically placed on the surface of the bacterial cellulose base membrane obtained in the step two;
step four, preparing a tubular bacterial cellulose hydrogel film with the length of 10-30 mm and the film thickness of 0.01-1 mm on the outer rotating surface of the section A of the round bar by adopting a film liquid interface culture technology;
step five, slowly pushing the tubular bacterial cellulose hydrogel film to the section B from the section A of the round rod through the middle section with the taper, so that the inner diameter of the tubular bacterial cellulose hydrogel film is gradually increased, and the bacterial cellulose nanofibers are oriented in situ along the circumferential direction;
and sixthly, putting the round bar with the bacterial cellulose hydrogel film into deionized water, cleaning for 2 times, then putting the round bar into the deionized water, heating and boiling, after the bacterial cellulose hydrogel film turns white from light yellow, putting the round bar into 0.5 mol/L NaOH solution, boiling for 20 minutes, finally boiling in the deionized water, repeating the boiling for 3-4 times, and washing with the deionized water until the round bar is neutral.
And seventhly, drying the cleaned round bar with the bacterial cellulose hydrogel film in an oven at 60 ℃ for 6-12 hours, and then taking down the tubular bacterial cellulose dry film to obtain the small blood vessel stent with the bacterial cellulose nanofibers oriented along the circumferential direction, wherein the inner diameter of the small blood vessel stent is 2-6 millimeters, the wall thickness of the small blood vessel stent is 0.01-1 millimeter, and the length of the small blood vessel stent is 10-30 millimeters.
Further, the preparation method of the small blood vessel stent with the nano-fiber oriented along the circumferential direction is provided, wherein,
in the second step, the strains at least comprise acetobacter xylinum, acetobacter aceti, acetobacter gluconicum, acetobacter acetogenes and acetobacter pasteurianus.
The round bar in the third step at least comprises a glass round bar, a ceramic round bar, an alkali-boiling resistant metal round bar and an alkali-boiling resistant high polymer material round bar.
The specific process of the fourth step is that the mixture is in a mist form and is according to 0.012-0.025 m L/cm2Spraying amount of the obtained productSpraying a culture medium on the contact surface of the round bar and the bacterial cellulose base membrane from a sample inlet hole at the upper end of the oxygen permeable silicone tube, spraying again after the culture medium on the bacterial cellulose base membrane is completely consumed, and repeatedly spraying for 50-200 times; thus, the tubular bacterial cellulose hydrogel film with the length of 10-30 mm and the film thickness of 0.01-1 mm is prepared on the outer surface of the section A of the round bar.
Compared with the prior art, the invention has the beneficial effects that:
the diameter of the small vessel stent prepared by the invention is 2-6 mm, the thickness of the vessel wall is controllable, and the minimum thickness can be as small as 10 microns. The small blood vessel stent has a bionic structure, wherein fibers with the diameter smaller than 100 nanometers are oriented in situ along the circumferential direction, the pores of the stent are small, blood seepage can be prevented, and rapid endothelialization is easy to realize. In addition, the diameter of the stent is controllable, and the thickness of the stent is adjustable, so that the stent becomes a small blood vessel stent or graft with great development prospect.
Drawings
FIG. 1(a) is a schematic cross-sectional structure diagram of a small vessel stent with nanofibers oriented in the circumferential direction;
FIG. 1(b) is a schematic diagram of the overall structure of a small vessel stent;
FIG. 2(a) is a photograph 1 of a small vessel stent prepared in example 1 of the present invention;
FIG. 2(b) is a photograph 2 of a small vessel stent prepared in example 1 of the present invention;
FIG. 3(a) is a scanning electron micrograph of the oriented arrangement of bacterial cellulose fibers of the small vessel stent prepared in example 1 of the present invention;
FIG. 3(b) is a partial enlarged view of the directional arrangement of bacterial cellulose fibers of the small vessel stent of FIG. 3 (a).
Detailed Description
The design idea of the invention is that the structure of the prepared small vessel stent has similarity with the fiber arrangement structure of natural vessels, so that the small vessel stent has the performance of facilitating cell adhesion, proliferation and final endothelialization. The small blood vessel stent is composed of bacterial cellulose nanofibers which are circumferentially arranged, wherein the diameter of the nanofibers is smaller than 100 nanometers, the diameter of the small blood vessel stent is 2-6 millimeters, the thickness of the tube wall is controllable, and the minimum thickness can be as small as 10 micrometers. The preparation method mainly comprises the following steps: the method comprises the steps of forming a bacterial cellulose hydrogel membrane with the length of 10-30 mm, the membrane thickness of 0.01-1 mm and the inner diameter of 2-6 mm in situ on the outer rotary surface of a round rod with the diameter changing (the outer diameter of a thick section of the round rod is 1.3-1.4 times of the outer diameter of a thin section, and an intermediate transition section is arranged between the thin section and the thick section) by adopting a membrane-liquid interface culture technology, then moving the hydrogel membrane from the thin section end to the thick section end of the round rod, gradually increasing the inner diameter of a tubular bacterial cellulose hydrogel by a displacement method, forcing bacterial cellulose fibers to be oriented in situ along the circumferential direction, taking out the round rod after heating, drying and shaping, and finally obtaining the small vessel stent with the bacterial cellulose nanofibers oriented along the circumferential direction and controllable tube wall thickness.
The invention is further illustrated with reference to the following figures and specific examples, which are not intended to limit the invention in any way.
Example 1, preparation of a small vessel stent, comprising the steps of:
step one, preparing a culture medium, namely sequentially adding glucose (25 g/L), yeast powder (7.5 g/L), peptone (10 g/L) and disodium hydrogen phosphate (10 g/L) into a beaker filled with 1000 ml of ultrapure water, stirring until the components are completely dissolved, adjusting the pH value of a system to be 4-5 by using glacial acetic acid to prepare the culture medium, and then placing the culture medium into a sterilization pot to sterilize for 40 minutes under the conditions of the temperature of 115 ℃ and the pressure of 0.1 MPa.
Step two, preparing a bacterial cellulose base membrane: the strain is inoculated into the culture medium under a sterile environment. The strain in this example is acetobacter xylinum. The strain can also be selected from one of acetobacter aceti, acetobacter gluconicum, acetobacter acetogenes and acetobacter pasteurianus; and statically culturing the inoculated culture medium at the temperature of 30 ℃ for 3 days to obtain a bacterial cellulose hydrogel membrane with the thickness of about 2.5 mm, wherein the bacterial cellulose hydrogel membrane is used as a basement membrane for membrane-liquid interface culture.
And step three, taking a round rod, wherein the round rod in the embodiment is a glass round rod, and the round rod can also be one of a ceramic round rod, an alkali-boiling-resistant metal round rod and an alkali-boiling-resistant high polymer material round rod. The total length of the glass round rod is 260 mm, the glass round rod is sequentially provided with a thin section, a middle section and a thick section from one end to the other end, the length of the thin section is 30 mm, and the diameter of the thin section is 2.5 mm; the length of the thick section is 30 mm, and the diameter is 3.5 mm; the middle section has a length of 200 mm and a diameter that increases gradually (equal slope) from 2.5 mm at the end of the thin section to 3.5 mm at the end of the thick section; and (3) after ultraviolet sterilization, fixing the thin section in an oxygen-permeable silica gel tube with a sample inlet at the upper end, and vertically placing the thin section on the surface of the bacterial cellulose base membrane obtained in the second step.
Step four, preparing a tubular bacterial cellulose hydrogel membrane with the length of 30 mm and the membrane thickness of 1.8 mm on the outer rotating surface of the thin section of the glass round rod by adopting the membrane liquid interface culture technology disclosed in the published patent document (a through membrane bracket and a preparation method thereof, application number 201910715079.9); the specific process is as follows:
in the form of a mist and at a rate of 0.018m L/cm2Spraying the culture medium obtained in the step one on the contact surface of the glass round bar and the bacterial cellulose base membrane from a sample inlet hole at the upper end of the oxygen permeable silicone tube, spraying again after the culture medium on the bacterial cellulose base membrane is completely consumed, and repeatedly spraying for 200 times; a tubular bacterial cellulose hydrogel film with the length of 30 mm and the film thickness of 1.8 mm is formed on the outer rotating surface of the thin section of the glass round rod.
And step five, slowly pushing the tubular bacterial cellulose hydrogel film on the round glass rod from the thin section to the thick section through the middle section with the taper, and gradually increasing the inner diameter of the tubular bacterial cellulose hydrogel film to the outer diameter (namely 3.5 mm) of the thick section so as to enable the bacterial cellulose nanofibers in the tubular bacterial cellulose hydrogel film to be oriented in the circumferential direction.
And sixthly, putting the glass round bar with the bacterial cellulose hydrogel film on the surface into deionized water, cleaning for 2 times, then putting the glass round bar into the deionized water, heating and boiling, putting the glass round bar into 0.5 mol/L NaOH solution, heating and boiling for 20 minutes after the film turns white from light yellow, and finally boiling for 4 times in the deionized water, and washing the glass round bar to be neutral by the deionized water.
And step seven, drying the cleaned glass round bar with the bacterial cellulose hydrogel film on the surface in an oven at 60 ℃ for 10 hours, and then removing the bacterial cellulose dry film to obtain the small blood vessel stent with the bacterial cellulose diameter smaller than 100 nanometers and in-situ circumferential orientation, wherein as can be seen from fig. 1(a) and 1(b), the small blood vessel stent is uniformly surrounded by the bacterial cellulose nanofibers and axially extends to form a round tube shape, the length of the small blood vessel stent is about 30 millimeters, the thickness of the small blood vessel stent is about 0.5 millimeters, the inner diameter of the small blood vessel stent is about 3.5 millimeters, macroscopic photographs of the small blood vessel stent are shown in fig. 2(a) and 2(b), and fig. 3(a) and 3(b) show SEM photographs in which the bacterial cellulose nanofibers are directionally arranged.
Example 2, preparation of small vessel stents comprising the following steps:
step one, the same as example 1.
Step two, the same as example 1.
Step three, different from the embodiment 1, the total length of the glass round rod in the embodiment is 200 mm, the length of the thin section is 20 mm, and the diameter is 3.5 mm; the length of the thick section is 20 mm, and the diameter is 4.6 mm; the middle section has a length of 160 mm and a diameter that gradually increases (equal in slope) from 3.5 mm at the end of the thin section to 4.6 mm at the end of the thick section; otherwise, the same procedure as in example 1 was repeated.
Step four, which is different from example 1 in that the number of spraying was 140, thereby forming a bacterial cellulose tubular hydrogel having a length of 20 mm and a thickness of 2.0 mm, which was attached to the surface of revolution of a thin section of a glass rod having an outer diameter of about 3.5 mm.
And step five, slowly pushing the tubular bacterial cellulose hydrogel film on the round glass rod from the thin section to the thick section through the middle section with the taper, and gradually increasing the inner diameter of the tubular bacterial cellulose hydrogel film to the outer diameter (namely 4.6 millimeters) of the thick section so as to enable the bacterial cellulose nanofibers in the tubular bacterial cellulose hydrogel film to be oriented in the circumferential direction.
Step six, the same as example 1.
Seventhly, as in the embodiment 1, the small blood vessel stent with the bacterial cellulose nanofibers oriented along the circumferential direction is finally obtained, wherein the length of the small blood vessel stent is about 20 millimeters, the thickness of the small blood vessel stent is about 0.6 millimeter, and the inner diameter of the small blood vessel stent is about 4.6 millimeters.
Example 3, preparation of small vessel stents comprising the following steps:
step one, the same as example 1.
Step two, the same as example 1.
Step three, different from the embodiment 1, the total length of the glass round rod in the embodiment is 214 mm, the length of the thin section is 17 mm, and the diameter is 4.0 mm; the length of the thick section is 17 mm, and the diameter is 5.6 mm; the middle section has a length of 180 mm and a diameter that gradually increases (equal in slope) from 4.0 mm at one end of the thin section to 5.6 mm at one end of the thick section; otherwise, the same procedure as in example 1 was repeated.
Step four, which is different from example 1 in that the number of spraying was 110, thereby forming a bacterial cellulose tubular hydrogel having a length of 17 mm and a thickness of 1.8 mm, which was attached to the surface of revolution of a thin section of a glass rod having an outer diameter of about 4.0 mm.
And step five, slowly pushing the tubular bacterial cellulose hydrogel film on the round glass rod from the thin section to the thick section through the middle section with the taper, and gradually increasing the inner diameter of the tubular bacterial cellulose hydrogel film to the outer diameter (namely 5.6 millimeters) of the thick section B so as to enable the bacterial cellulose nanofibers in the tubular bacterial cellulose hydrogel film to be oriented in the circumferential direction.
Step six, the same as example 1.
Seventhly, as in the embodiment 1, the small blood vessel stent with the bacterial cellulose nanofibers oriented along the circumferential direction is finally obtained, wherein the length of the small blood vessel stent is about 17 millimeters, the thickness of the small blood vessel stent is about 0.4 millimeter, and the inner diameter of the small blood vessel stent is about 5.6 millimeters.
Although the present invention has been described in detail with reference to the drawings, the present invention is not limited to the above embodiments, which are only illustrative and not restrictive, and those skilled in the art can make many modifications without departing from the spirit of the present invention, which falls within the protection of the present invention.
Claims (6)
1. The small blood vessel stent with the nanofibers oriented in the circumferential direction is characterized in that the small blood vessel stent is formed by uniformly surrounding bacterial cellulose nanofibers into a circular tube shape, the bacterial cellulose nanofibers are arranged in the circumferential direction, and the small blood vessel stent is 2-6 mm in inner diameter, 0.01-1 mm in wall thickness and 10-30 mm in length.
2. The method for preparing the small vessel stent with the nanofibers oriented in the circumferential direction according to claim 1, wherein a bacterial cellulose hydrogel is formed in situ on a rotating surface of a round rod, the inner diameter of the tubular bacterial cellulose hydrogel is gradually increased by a displacement method to achieve the in-situ circumferential orientation of the nanofibers, and after heating, drying and shaping, the round rod is removed to obtain the small vessel stent with the nanofibers oriented in the circumferential direction and the controllable wall thickness of the tube.
3. The method for preparing a small vessel stent with nanofibers oriented in the circumferential direction according to claim 2, characterized by the following steps:
step one, preparing a culture medium by adopting a conventional method, and placing the culture medium in a sterilization pot for high-temperature and high-pressure sterilization for 30-60 minutes;
step two, preparing a bacterial cellulose base membrane: inoculating the strain into a culture medium in an aseptic environment; statically culturing the inoculated culture medium at 30 ℃ for 3 days to obtain a bacterial cellulose base membrane;
taking a round bar, wherein the round bar comprises an A section, a middle section and a B section which are coaxially connected in sequence; the diameter of the section A is Da, the Da is 1.5-4.5 mm, and the length of the section A is 10-30 mm; the diameter of the section B is Db, Db is 2-6 mm, Db is 1.3-1.4 Da, and the length of the section B is 10-30 mm; the diameter of the connecting end of the middle section and the section A is Da, the diameter of the connecting end of the middle section and the section B is Db, the length of the middle section is 100-200 mm, the middle section is a diameter gradually-changing section, and the diameter gradually changes from Da to Db along the length of the middle section; after ultraviolet sterilization, the round rod is fixed in an oxygen-permeable silica gel tube with a sampling hole at the upper end downwards according to the section A, and is vertically placed on the surface of the bacterial cellulose base membrane obtained in the step two;
step four, preparing a tubular bacterial cellulose hydrogel film with the length of 10-30 mm and the film thickness of 0.01-1 mm on the outer rotating surface of the section A of the round bar by adopting a film liquid interface culture technology;
step five, slowly pushing the tubular bacterial cellulose hydrogel film from the section A of the round rod to the section B through the middle section with the taper, so that the inner diameter of the tubular bacterial cellulose hydrogel film is gradually increased, and the bacterial cellulose nanofibers are oriented along the circumferential direction;
and sixthly, putting the round bar with the bacterial cellulose hydrogel film into deionized water, cleaning for 2 times, then putting the round bar into the deionized water, heating and boiling, after the bacterial cellulose hydrogel film turns white from light yellow, putting the round bar into 0.5 mol/L NaOH solution, boiling for 20 minutes, finally boiling in the deionized water, repeating the boiling for 3-4 times, and washing with the deionized water until the round bar is neutral.
And seventhly, drying the cleaned round bar with the bacterial cellulose hydrogel film in an oven at 60 ℃ for 6-12 hours, and then taking down the tubular bacterial cellulose dry film to obtain the small blood vessel stent with the bacterial cellulose nanofibers oriented along the circumferential direction, wherein the inner diameter of the small blood vessel stent is 2-6 millimeters, the wall thickness of the small blood vessel stent is 0.01-1 millimeter, and the length of the small blood vessel stent is 10-30 millimeters.
4. The method for preparing the small blood vessel stent with the nanofibers oriented in the circumferential direction according to claim 3, wherein the specific process of the fourth step is to spray the nanofibers at 0.012-0.025 m L/cm2Spraying the culture medium obtained in the step one on a contact surface of the round bar and the bacterial cellulose base membrane from a sample inlet hole at the upper end of the oxygen permeable silicone tube, spraying again after the culture medium on the bacterial cellulose base membrane is completely consumed, and repeatedly spraying for 50-200 times; thus, the tubular bacterial cellulose hydrogel film with the length of 10-30 mm and the film thickness of 0.01-1 mm is prepared on the outer surface of the section A of the round bar.
5. The method for preparing a small vessel stent with nanofibers oriented in the circumferential direction according to claim 3, wherein the round rods at least comprise glass round rods, ceramic round rods, alkali-boiling resistant metal round rods and alkali-boiling resistant high polymer material round rods.
6. The method for preparing a small vessel stent with nanofibers oriented in a circumferential direction according to claim 3, wherein in the second step, the bacterial species at least include Acetobacter xylinum, Acetobacter aceti, Acetobacter xylinum, Acetobacter acetogenium and Acetobacter pasteurianus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010220104.9A CN111388760B (en) | 2020-03-25 | 2020-03-25 | Small blood vessel stent with nano fibers oriented along circumferential direction and preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010220104.9A CN111388760B (en) | 2020-03-25 | 2020-03-25 | Small blood vessel stent with nano fibers oriented along circumferential direction and preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111388760A true CN111388760A (en) | 2020-07-10 |
| CN111388760B CN111388760B (en) | 2022-03-15 |
Family
ID=71411079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010220104.9A Expired - Fee Related CN111388760B (en) | 2020-03-25 | 2020-03-25 | Small blood vessel stent with nano fibers oriented along circumferential direction and preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111388760B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0200409A2 (en) * | 1985-04-16 | 1986-11-05 | Agency Of Industrial Science And Technology | Moulded material comprising bacteria-produced cellulose |
| CN101584882A (en) * | 2009-06-10 | 2009-11-25 | 海南椰国食品有限公司 | Vascular stent material of tissue engineering and manufacturing method thereof |
| CN102641161A (en) * | 2012-04-23 | 2012-08-22 | 东华大学 | Composite structure artificial blood vessel and dynamic preparation method thereof |
| CN102978254A (en) * | 2012-12-26 | 2013-03-20 | 东华大学 | Method for culturing bacterial cellulose through pulsation |
| CN103462726A (en) * | 2013-08-28 | 2013-12-25 | 苏州英络医疗器械有限公司 | Novel covered stent and manufacturing method thereof |
| CN106512087A (en) * | 2016-12-06 | 2017-03-22 | 北京航空航天大学 | Artificial blood vessel stent with aligned fibers and manufacturing method of artificial blood vessel stent |
| CN110559103A (en) * | 2019-08-05 | 2019-12-13 | 华东交通大学 | Through-membrane stent and preparation method thereof |
-
2020
- 2020-03-25 CN CN202010220104.9A patent/CN111388760B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0200409A2 (en) * | 1985-04-16 | 1986-11-05 | Agency Of Industrial Science And Technology | Moulded material comprising bacteria-produced cellulose |
| CN101584882A (en) * | 2009-06-10 | 2009-11-25 | 海南椰国食品有限公司 | Vascular stent material of tissue engineering and manufacturing method thereof |
| CN102641161A (en) * | 2012-04-23 | 2012-08-22 | 东华大学 | Composite structure artificial blood vessel and dynamic preparation method thereof |
| CN102978254A (en) * | 2012-12-26 | 2013-03-20 | 东华大学 | Method for culturing bacterial cellulose through pulsation |
| CN103462726A (en) * | 2013-08-28 | 2013-12-25 | 苏州英络医疗器械有限公司 | Novel covered stent and manufacturing method thereof |
| CN106512087A (en) * | 2016-12-06 | 2017-03-22 | 北京航空航天大学 | Artificial blood vessel stent with aligned fibers and manufacturing method of artificial blood vessel stent |
| CN110559103A (en) * | 2019-08-05 | 2019-12-13 | 华东交通大学 | Through-membrane stent and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111388760B (en) | 2022-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101921700B (en) | Device and method for preparing hollow heteromorphic bacteria cellulose material | |
| Hong et al. | Preliminary study on biosynthesis of bacterial nanocellulose tubes in a novel double-silicone-tube bioreactor for potential vascular prosthesis | |
| CN101584882B (en) | Vascular stent material of tissue engineering and manufacturing method thereof | |
| CN111714706B (en) | Vascular stent capable of promoting vascular cell proliferation and secreting extracellular matrix, preparation method of vascular stent and active artificial blood vessel | |
| JP6858177B2 (en) | Nanocellulose-based medical implant | |
| US20030013163A1 (en) | Method and device for producing shaped microbial cellulose for use as a biomaterial, especially for microsurgery | |
| US11298225B2 (en) | Medical implant with seamlessly connected bacterial cellulose | |
| CA2400372A1 (en) | Method and device for producing shaped microbial cellulose for use as biomaterial, especially for microsurgery | |
| CN101663000A (en) | Medical implant and manufacturing process thereof | |
| CN111388760B (en) | Small blood vessel stent with nano fibers oriented along circumferential direction and preparation method | |
| CN101652471B (en) | Process and support structure for the cultivation of living cells | |
| CN106938057A (en) | A kind of fibroin fiber support and preparation method thereof | |
| CN108245712B (en) | Preparation method and application of bacterial cellulose small-diameter artificial blood vessel | |
| CN102641160B (en) | Artificial bile duct bionic stent with double-layered compound structure and preparation method of artificial bile duct bionic stent | |
| CN107715179A (en) | Composite artificial minute vessel stent and preparation method thereof | |
| CN110559103B (en) | Through-membrane stent and preparation method thereof | |
| CN113967112A (en) | Preparation method of 3D-printed intravascular absorbable stent with anticoagulation function | |
| CN110215541A (en) | A kind of tubulose Nano bacteria cellulose/source of fish gelatin composite material and preparation method thereof and artificial blood vessel's application | |
| CN109912828A (en) | A kind of Nano bacteria cellulose base tube and its preparation method and application of inner surface lines modification | |
| JP2002521142A (en) | Urea-producing organ substitute | |
| CN111700710B (en) | Template for tissue engineering material and tissue engineering material | |
| PL230643B1 (en) | Tracheal prosthesis and method for producing it | |
| JP2005320657A (en) | Method for producing cellulose product using cellulose-producing bacterium | |
| CN115282346A (en) | Silk/bacterial cellulose composite esophagus bionic scaffold and preparation method thereof | |
| CN115154659A (en) | Implant and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20220315 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |